bg
A

Acumen Pharmaceuticals (ABOS)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Acumen Pharmaceuticals (ABOS)

Acumen Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing a novel disease-modifying approach to target causes of Alzheimer's disease. Acumen Pharmaceuticals serves customers worldwide.

  • USD4.22
  • USD4.23
  • USD4.11
  • USD11.31
  • -33.60%
  • --
  • 229.96k
  • 266.82k
  • 258M
  • 3.52
  • -60.40%

Unlock More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.